Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,501
Total Claims
$1.1M
Drug Cost
522
Beneficiaries
$2,035
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-66%
Opioid rate vs peers
0.9% vs 2.6% avg
+91%
Cost per patient vs peers
$2,035 vs $1,068 avg
+23%
Brand preference vs peers
11.1% vs 9.0% avg
Opioid Prescribing
0.9%
Opioid Rate
102
Opioid Claims
$998
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,258 claims · $885K
Generic: 10,080 claims · $167K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 144 | $191K |
| Insulin Glargine,hum.Rec.Anlog | 90 | $76K |
| Semaglutide | 54 | $59K |
| Apixaban | 75 | $59K |
| Sitagliptin Phosphate | 44 | $56K |
| Tirzepatide | 38 | $44K |
| Empagliflozin | 32 | $43K |
| Linaclotide | 29 | $41K |
| Semaglutide | 25 | $31K |
| Tiotropium Bromide | 28 | $28K |
| Linagliptin | 19 | $22K |
| Insulin Degludec | 18 | $13K |
| Fluticasone/Vilanterol | 28 | $12K |
| Potassium Chloride | 235 | $10K |
| Insulin Detemir | 13 | $9,747 |
Prescribing Profile
Patient Profile
69
Avg Age
66%
Female
1.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data